Technology Solutions

FDA, IBM partner on the secure exchange of clinical data

Monday, January 23, 2017

Secure storage and controlled access to sensitive patient data are critical aspects of the clinical trial process. Investigators may need to access huge data sets shared across national and international sites. The amount and sheer number of types of data is rapidly increasing as the use of mobile and wearable devices and the querying of genomic databases are incorporated into trial design.

[Read More]

3E, Dotmatics partner on scientific informatics and environmental compliance

Wednesday, January 18, 2017

3E Company, a provider of environmental health and safety (EH&S) compliance and information management services, has announced a strategic alliance with Dotmatics, a provider of scientific informatics solutions and services to the life sciences industry. The alliance will offer Dotmatics and 3E customers access to a range of integrated applications designed to optimize scientific information management, chemical and formula risk analysis, environmental compliance and workplace safety while helping to streamline processes, reduce costs and increase efficiency. Having access to reliable and up-to-date scientific and regulatory information enables life sciences businesses to improve knowledge management, data storage and decision support. 3E Company is a Verisk Analytics business.

[Read More]

Merck KGaA, Palantir partnership on healthcare acceleration

Monday, January 16, 2017

Merck KGaA, a science and technology company, has announced a partnership with Palantir Technologies, developer of data integration and analysis software, at Palantir’s headquarters in Palo Alto, California. The partnership will leverage Palantir’s advanced data analytics capabilities to help Merck better and more rapidly develop and deliver medicines to patients, commercialize new products and improve patient outcomes. Initially, Merck will apply Palantir’s technology to cancer treatment and patient services. Ultimately Merck plans to deploy Palantir’s technology across all three of the company’s business sectors Healthcare, Life Science and Performance Materials. Financial details were not disclosed.

[Read More]

St. Jude cybersecurity vulnerabilities spark medical device hacking debate

Monday, January 16, 2017

A recent cybersecurity scandal involving St. Jude’s Merlin@home device sparked a renewed discussion within the medical device industry about the best way to address security flaws discovered by independent security experts, sometimes called “white hat” hackers. As medical devices become increasingly vulnerable to cyber attack, the industry has broadly accepted its new responsibility of continuously protecting approved devices from potential security breaches.

[Read More]

IBM Watson Health, FDA collaborate on blockchain technology

Thursday, January 12, 2017

IBM Watson Health has signed a research initiative with the FDA aimed at defining a secure, efficient and scalable exchange of health data using blockchain technology. IBM and the FDA will explore the exchange of owner mediated data from several sources, such as Electronic Medical Records, clinical trials, genomic data, and health data from mobile devices, wearables and the “Internet of Things.” The initial focus will be on oncology-related data.

[Read More]

Philips, Illumina partner on integrated genomics solutions for oncology

Monday, January 9, 2017

Royal Philips, a global leader in health technology, and Illumina, a global leader in DNA sequencing and array-based technologies, has announced a strategic collaboration that aims to integrate Illumina’s sequencing systems for large-scale analysis of genetic variation and function and Philips’ IntelliSpace Genomics clinical informatics platform, and to coordinate marketing and sales of the resulting solutions. Philips and Illumina will also seek to engage in clinical research collaborations with health systems in the U.S. that want to develop precision medicine programs in oncology.

[Read More]